Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Editing DNA Methylation in vivo [WGBS]

ABSTRACT: DNA methylation is an epigenetic mechanism essential for orchestrating gene expression. Precise editing of DNA methylation has emerged as a new method to dissect its biological function in a DNA sequence specific manner with great potential to treat human diseases. However, applications of DNA methylation editing are largely in vitro. An experimental system to systematically investigate in vivo DNA methylation editing is needed to reveal its full therapeutic potential. We generated two transgenic mouse lines carrying an inducible dCas9-Dnmt3a or dCas9-Tet1 editor to enable cell-type specific methylation editing in vivo. We demonstrated that targeted methylation of the Psck9 promoter in the liver of dCas9-Dnmt3a mice reduced Psck9 expression and lowered plasma low-density lipoprotein cholesterol level to reduce the risk for cardiovascular diseases. Targeted demethylation of the Mecp2 promoter by dCas9-Tet1 reactivated Mecp2 expression from the inactive X chromosome in the brain of Mecp2 heterozygous Rett syndrome mice, suggesting a promising therapeutic approach for Rett syndrome and other X-linked diseases. Genome-wide sequencing analysis showed no detectable off-target at the transcriptional level in the methylation edited mice. These results demonstrate the feasibility and versatility of methylation editing in vivo, to explore DNA methylation in normal physiology and develop treatments for human diseases.

ORGANISM(S): Mus musculus

PROVIDER: GSE280074 | GEO | 2025/11/12

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Editing DNA Methylation in vivo [ChIP-Seq]

Project description:DNA methylation is an epigenetic mechanism essential for orchestrating gene expression. Precise editing of DNA methylation has emerged as a new method to dissect its biological function in a DNA sequence specific manner with great potential to treat human diseases. However, applications of DNA methylation editing are largely in vitro. An experimental system to systematically investigate in vivo DNA methylation editing is needed to reveal its full therapeutic potential. We generated two transgenic mouse lines carrying an inducible dCas9-Dnmt3a or dCas9-Tet1 editor to enable cell-type specific methylation editing in vivo. We demonstrated that targeted methylation of the Psck9 promoter in the liver of dCas9-Dnmt3a mice reduced Psck9 expression and lowered plasma low-density lipoprotein cholesterol level to reduce the risk for cardiovascular diseases. Targeted demethylation of the Mecp2 promoter by dCas9-Tet1 reactivated Mecp2 expression from the inactive X chromosome in the brain of Mecp2 heterozygous Rett syndrome mice, suggesting a promising therapeutic approach for Rett syndrome and other X-linked diseases. Genome-wide sequencing analysis showed no detectable off-target at the transcriptional level in the methylation edited mice. These results demonstrate the feasibility and versatility of methylation editing in vivo, to explore DNA methylation in normal physiology and develop treatments for human diseases.

2025-11-12 | GSE280073 | GEO

Editing DNA Methylation in vivo [RNA-Seq]

2025-11-12 | GSE280072 | GEO

Multiplex Epigenome Editing of MECP2 to Rescue Rett Syndrome Neurons [ChIP-BS-Seq]

Project description:Rett syndrome (RTT) is an X-linked neurodevelopmental disorder caused by loss-of-function heterozygous mutations of MECP2. Reactivation of the silent wild-type MECP2 allele on the inactive X chromosome (Xi) represents a promising therapeutic opportunity for female RTT patients. Here, we applied a multiplex epigenome editing approach to reactivate MECP2 on Xi. Demethylation of the MECP2 promoter by dCas9-Tet1 with target sgRNA reactivated MECP2 on Xi in RTT hESCs without detectable off-target effects at the transcriptome level. Neurons derived from methylation edited RTT hESCs reversed the smaller soma size and electrophysiological abnormalities. Insulation of the methylation edited MECP2 locus in RTT neurons by dCpf1-CTCF with target crRNA stabilized MECP2 reactivation and rescued the RTT-related neuronal defects, providing a proof-of-concept study for multiplex epigenome editing to treat RTT.

2025-07-11 | GSE208257 | GEO

Multiplex Epigenome Editing of MECP2 to Rescue Rett Syndrome Neurons (WGBS)

2023-09-01 | GSE214549 | GEO

Multiplex Epigenome Editing of MECP2 to Rescue Rett Syndrome Neurons (ChIP-Seq)

2023-09-01 | GSE214547 | GEO

Multiplex Epigenome Editing of MECP2 to Rescue Rett Syndrome Neurons [ChIP-Seq]

2025-07-11 | GSE208221 | GEO

Multiplex Epigenome Editing of MECP2 to Rescue Rett Syndrome Neurons [RNA-Seq]

2025-07-11 | GSE208193 | GEO

Multiplex Epigenome Editing of MECP2 to Rescue Rett Syndrome Neurons [4C]

2025-07-11 | GSE208056 | GEO

Editing DNA methylation in the mammalian genome

Project description:Mammalian DNA methylation is a critical epigenetic mechanism orchestrating gene expression networks in many biological processes. However, investigation of the functions of specific methylation events remains challenging. Here, we demonstrate that fusion of Tet1 or Dnmt3a with a catalytically inactive Cas9 (dCas9) enables targeted DNA methylation editing. Targeting of the dCas9-Tet1 or -Dnmt3a fusion protein to methylated or unmethylated promoter sequences caused activation or silencing, respectively, of an endogenous reporter. Targeted demethylation of the BDNF promoter IV or the MyoD distal enhancer by dCas9-Tet1 induced BDNF expression in post-mitotic neurons or activated MyoD facilitating reprogramming of fibroblasts into myoblasts, respectively. Targeted de novo methylation of a CTCF loop anchor site by dCas9-Dnmt3a blocked CTCF binding and interfered with DNA looping, causing altered gene expression in the neighboring loop. Finally, we show that these tools can edit DNA methylation in mice demonstrating their wide utility for functional studies of epigenetic regulation.

2016-09-23 | GSE83890 | GEO

Multiplex Epigenome Editing of MECP2 to Rescue Rett Syndrome Neurons (RNA-Seq)

2023-09-01 | GSE214548 | GEO